Veranova is your next great decision
Discover new ways to advance your science with Veranova.
Contact usIndustry Roundtable: Small-Molecule APIs
“The rise in chronic diseases and the push for innovative therapies are driving demand for highly potent APIs (HPAPIs) and complex small molecules. In addition, the race to launch innovative therapies demands shorter development timelines. Digitalization, including AI-driven process optimization and data integration, is a game-changer by streamlining workflows and leveraging predictive analytics.”
Veranova’s SVP of Development Operations and Chief Technology Officer, Rohtash Kumar, spoke with DCAT ValueChain Insights to discuss the key issues shaping development and manufacturing of small-molecule APIs.